164 related articles for article (PubMed ID: 35357369)
1. Safety and efficacy of compounded bioidentical hormone therapy (cBHT) in perimenopausal and postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
Liu Y; Yuan Y; Day AJ; Zhang W; John P; Ng DJ; Banov D
Menopause; 2022 Feb; 29(4):465-482. PubMed ID: 35357369
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Local oestrogen for vaginal atrophy in postmenopausal women.
Lethaby A; Ayeleke RO; Roberts H
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001500. PubMed ID: 27577677
[TBL] [Abstract][Full Text] [Related]
4. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
5. Bioidentical hormones for women with vasomotor symptoms.
Gaudard AM; Silva de Souza S; Puga ME; Marjoribanks J; da Silva EM; Torloni MR
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010407. PubMed ID: 27479272
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral phytoestrogens on endometrial thickness and breast density of perimenopausal and postmenopausal women: A systematic review and meta-analysis.
Mareti E; Abatzi C; Vavilis D; Lambrinoudaki I; Goulis DG
Maturitas; 2019 Jun; 124():81-88. PubMed ID: 31097185
[TBL] [Abstract][Full Text] [Related]
7. Effects of mind-body exercise on perimenopausal and postmenopausal women: a systematic review and meta-analysis.
Xu H; Liu J; Li P; Liang Y
Menopause; 2024 May; 31(5):457-467. PubMed ID: 38669625
[TBL] [Abstract][Full Text] [Related]
8. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
9. Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making.
Thompson JJ; Ritenbaugh C; Nichter M
BMC Womens Health; 2017 Oct; 17(1):97. PubMed ID: 28969624
[TBL] [Abstract][Full Text] [Related]
10. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
Tan YH; Lethaby A
Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
[TBL] [Abstract][Full Text] [Related]
11. Short and long term effects of tibolone in postmenopausal women.
Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
[TBL] [Abstract][Full Text] [Related]
12. Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update.
Meziou N; Scholfield C; Taylor CA; Armstrong HL
Menopause; 2023 Jun; 30(6):659-671. PubMed ID: 37159867
[TBL] [Abstract][Full Text] [Related]
13. Long term hormone therapy for perimenopausal and postmenopausal women.
Farquhar CM; Marjoribanks J; Lethaby A; Lamberts Q; Suckling JA;
Cochrane Database Syst Rev; 2005 Jul; (3):CD004143. PubMed ID: 16034922
[TBL] [Abstract][Full Text] [Related]
14. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
15. Bioidentical Estrogen for Menopausal Depressive Symptoms: A Systematic Review and Meta-Analysis.
Whedon JM; KizhakkeVeettil A; Rugo NA; Kieffer KA
J Womens Health (Larchmt); 2017 Jan; 26(1):18-28. PubMed ID: 27603786
[TBL] [Abstract][Full Text] [Related]
16. Compounded bioidentical hormone products, a path forward.
MacArthur RB; Mattison D; Parker RM
J Am Pharm Assoc (2003); 2022; 62(1):42-48. PubMed ID: 34511371
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy of Vaginal Laser and Other Energy-based Treatments on Genital Symptoms in Postmenopausal Women: A Systematic Review and Meta-analysis.
Li F; Picard-Fortin V; Maheux-Lacroix S; Deans R; Nesbitt-Hawes E; McCormack L; Abbott J
J Minim Invasive Gynecol; 2021 Mar; 28(3):668-683. PubMed ID: 32791349
[TBL] [Abstract][Full Text] [Related]
18. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2006 Oct; (4):CD001500. PubMed ID: 17054136
[TBL] [Abstract][Full Text] [Related]
19. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Romero SA; Young K; Hickey M; Su HI
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
